Evidence map›Paper›PMID 12782689›Full record

ReviewJournal of the Royal Society of Medicine2003

An overview of the eye in diabetes.

Anil Negi, Stephen A Vernon

Abstract readReview
In one paragraph

Review in Journal of the Royal Society of Medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. RSC advances · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Monocarboxylate Transporters: Role and Regulation in Corneal Diabetes.Analytical cellular pathology (Amsterdam) · 2022
    Article
  9. Review
  10. Article
  11. Systemic diseases and the cornea.Experimental eye research · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Aqueous humor metabolomic profiles in association with diabetic mellitus.International journal of clinical and experimental pathology · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anil NegiEye and ENT Centre, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Stephen A Vernon

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The three papers in this symposium are based on presentations to an RSM meeting on the Diabetic Eye, held on 9 April 2003. The matter is particularly topical because the National Service Framework for Diabetes calls for a high-quality retinal screening programme. After a review of the various ophthalmic conditions likely to be encountered in diabetic patients (A Negi, S A Vernon) we proceed to the most important, diabetic retinopathy, with a discussion of screening methods (D M Squirrell, J F Talbot) and an account of laser treatments (J G F Dowler). Colour versions of the clinical photographs are available online [www.jrsm.org]. Publication was coordinated by Professor Susan Lightman, of Moorfields Eye Hospital, London, UK.

Indexed as

Diabetes ComplicationsAdultAgedAge FactorsCorneal DiseasesCranial Nerve DiseasesDiabetic RetinopathyDisease ProgressionEye DiseasesFemaleGlaucomaHumansLens DiseasesMaleMiddle AgedOptic Nerve Diseases

Identifiers

PMID12782689
PMCPMC539505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.